Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

MeSH Review:

Scleroderma, Limited

Farber, H.W. et al., Stratton, R.J. et al., Pope, J.E. et al., Takeuchi, F. et al., Clements, P.J. et al., et al.

Farber, Graven, Kokolski, Korn, Steen, Medsger,

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Scleroderma, Limited

Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma [1].
We describe a life threatening side effect of acute epoprostenol infusion (pulmonary edema) in a patient with pulmonary hypertension associated with limited scleroderma and discuss its management and potential etiology [1].
Diffuse blisters and erosions in a patient with limited scleroderma. Penicillamine-induced pemphigus foliaceus (PIPF) [2].
Patients with SSc with diffuse scleroderma had higher levels of ET-1 compared with those with limited scleroderma [3].

High impact information on Scleroderma, Limited

CONCLUSION: A decreasing DLCO is an excellent predictor of the subsequent development of isolated PHT in limited scleroderma [4].
None had rheumatoid arthritis, but 1 had limited scleroderma [5].
This woman had limited scleroderma for years and had medium vessel occlusive disease with gangrene eventually requiring midfoot amputations and chronic warfarin treatment [6].
Evidence for endothelial cell activation in scleroderma-associated pulmonary hypertension was inconsistent, with normal sE-selectin and normal sVCAM-1 in sera from patients with limited scleroderma and pulmonary hypertension [7].
Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil [8].

Chemical compound and disease context of Scleroderma, Limited

In contrast, C4A/Q0 was significantly increased in limited scleroderma (53.8%, p < 0.005, pc < 0.05) and SSc without a-SCL-70 (53.8%, p < 0.005, pc < 0.05) [9].

References

Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma. Farber, H.W., Graven, K.K., Kokolski, G., Korn, J.H. J. Rheumatol. (1999) [Pubmed]
Diffuse blisters and erosions in a patient with limited scleroderma. Penicillamine-induced pemphigus foliaceus (PIPF). McGovern, T.W., Bennion, S.D. Archives of dermatology. (1997) [Pubmed]
Significance of plasma endothelin-1 levels in patients with systemic sclerosis. Yamane, K., Miyauchi, T., Suzuki, N., Yuhara, T., Akama, T., Suzuki, H., Kashiwagi, H. J. Rheumatol. (1992) [Pubmed]
Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Steen, V., Medsger, T.A. Arthritis Rheum. (2003) [Pubmed]
Characterization of T-Cell Large Granular Lymphocyte Leukemia Associated with Sjogren's Syndrome-An Important but Underrecognized Association. Friedman, J., Schattner, A., Shvidel, L., Berrebi, A. Semin. Arthritis Rheum. (2006) [Pubmed]
The frequency and significance of anticardiolipin antibodies in scleroderma. Pope, J.E., Thompson, A. J. Rheumatol. (2000) [Pubmed]
Different patterns of endothelial cell activation in renal and pulmonary vascular disease in scleroderma. Stratton, R.J., Coghlan, J.G., Pearson, J.D., Burns, A., Sweny, P., Abraham, D.J., Black, C.M. QJM : monthly journal of the Association of Physicians. (1998) [Pubmed]
Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil. Clements, P.J., Peter, J.B., Agopian, M.S., Telian, N.S., Furst, D.E. J. Rheumatol. (1990) [Pubmed]
C4A and C4B null alleles are genetic markers of different types of systemic sclerosis in Japanese patients. Takeuchi, F., Nabeta, H., Hong, G.H., Matsuta, K., Tokunaga, K., Tanimoto, K., Nakano, K. Clinical and experimental rheumatology. (1998) [Pubmed]

Contributions to this collaborative article are from individual authors of WikiGenes or mined by the WikiGenes Data Mining Engine from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.